LML Visiting Scholar
Professor Timo Minssen is Professor of Biotechnology Law, specialising in legal aspects of biomedical innovation, at the University of Copenhagen (UCPH), Centre for Information & Innovation Law (CIIR). In 2016, Professor Minssen has been appointed as Visiting Research Fellow at the University of Cambridge, and has also been Visiting Research Fellow at the University of Oxford, Harvard Law School and the Chicago-Kent College of Law, as well as Max Planck stipendiate at the Max Planck Institute for Innovation & Competion in Munich. He was trained in the German Court system (Referendariat), worked for a short period at the European Patent Office (EPO) and was engaged in interdisciplinary epigenics-research at the Swedish Pufendorf Institute for Advanced Studies in Lund.
At the University of Copenhegen, Timo is scientific advisory board member of the Copenhagen Centre for Regulatory Sciences (CORS). He also heads the Copenhagen Biotech and&Pharma Forum (CBPF) and is PI and WP leader in four interdisciplinary pharma- & biotech- related research projects concerning User Generated Law, Synthetic Biology, Biobanking, Personalised Medicine, Additive Manufacturing and large European research infrastructures. He is a frequent lecturer on a variety of biotech and pharma related topics with many publications in leading international journals. In 2012 he published a study on the patentability of biopharmaceutical technology in Europe and in the U.S., which was awarded with the Swedish King Oscar stipendium. He is also a regular contributor on Harvard Law School's "Bill of Health" blog. At present he is finalising a book on pharmaceutical competition law with Oxford University Press.
Whilst in Cambridge, Professor Minssen's research will concentrate on several publications which are close to completion. These cover the areas of:
In addition, he will participate in panel discussions and present on on:
Professor Minssen's recent publications include:
For more of Professor Minssen's publications, see here.